June 20th, 2011 By: Paul Armentano, NORML Deputy Director The combined administration of the plant cannabinoids THC and CBD (cannabidiol) provide neuroprotection in rat models of Huntington’s Disease (HD), according to experimental data to be published in theJournal...
Madrid, Spain: Cannabis’ active components show promise in halting the progression of certain neurodegerative disorders and should be evaluated in clinical trials, according to a review published online in the British Journal of Pharmacology. An international...
